Published in Neurochem Res on March 10, 2015
Parkinson's disease: mechanisms and models. Neuron (2003) 14.84
Molecular pathways of neurodegeneration in Parkinson's disease. Science (2003) 7.55
NF-kappa B: a lesson in family values. Cell (1995) 7.33
Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology (1988) 6.79
Parkinson's disease. First of two parts. N Engl J Med (1998) 5.90
Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci (1999) 5.15
Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci (2002) 4.38
Protocol for the MPTP mouse model of Parkinson's disease. Nat Protoc (2007) 3.00
Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis (2009) 2.49
Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A (2007) 2.43
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety. J Neurochem (2001) 2.18
The role of oxidative stress in Parkinson's disease. J Parkinsons Dis (2013) 1.86
Inhibition of calpains prevents neuronal and behavioral deficits in an MPTP mouse model of Parkinson's disease. J Neurosci (2003) 1.74
Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis. J Neural Transm (1976) 1.54
The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease. Ann N Y Acad Sci (2003) 1.53
Glial cells and inflammation in Parkinson's disease: a role in neurodegeneration? Ann Neurol (1998) 1.47
Neuroinflammation in Parkinson's disease. Parkinsonism Relat Disord (2012) 1.38
Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice. Brain Res (2003) 1.32
Neuroinflammation in the living brain of Parkinson's disease. Parkinsonism Relat Disord (2009) 1.27
Purification and characterization of glia maturation factor beta: a growth regulator for neurons and glia. Proc Natl Acad Sci U S A (1989) 1.27
Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience (1993) 1.27
Chemokines in immune-mediated inflammation of the central nervous system. Cytokine Growth Factor Rev (1996) 1.19
A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines. J Neurochem (2007) 1.18
Neuroinflammation and oxidative stress: co-conspirators in the pathology of Parkinson's disease. Neurochem Int (2013) 1.15
Retinoic acid inhibits expression of TNF-alpha and iNOS in activated rat microglia. Glia (2005) 1.14
Cellular and molecular mediators of neuroinflammation in the pathogenesis of Parkinson's disease. Mediators Inflamm (2013) 1.12
New insights into Parkinson's disease. J Neurol (2003) 1.06
Neuroinflammation in the pathophysiology of Parkinson's disease: evidence from animal models to human in vivo studies with [11C]-PK11195 PET. Mov Disord (2007) 1.05
Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity. ASN Neuro (2013) 1.05
Fluoxetine prevents MPTP-induced loss of dopaminergic neurons by inhibiting microglial activation. Neuropharmacology (2011) 1.03
Complete amino acid sequence of bovine glia maturation factor beta. Proc Natl Acad Sci U S A (1990) 1.02
α7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation. J Neuroinflammation (2012) 0.98
Diminished cytokine and chemokine expression in the central nervous system of GMF-deficient mice with experimental autoimmune encephalomyelitis. Brain Res (2007) 0.97
Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. Exp Mol Pathol (2008) 0.95
Cannabinoid receptor type 1 protects nigrostriatal dopaminergic neurons against MPTP neurotoxicity by inhibiting microglial activation. J Immunol (2011) 0.92
Augmented expression of glia maturation factor in Alzheimer's disease. Neuroscience (2011) 0.91
Induction of glia maturation factor-beta in proximal tubular cells leads to vulnerability to oxidative injury through the p38 pathway and changes in antioxidant enzyme activities. J Biol Chem (2003) 0.89
Oxidative stress and Parkinson's disease. Handb Clin Neurol (2007) 0.89
Baicalein attenuates astroglial activation in the 1-methyl-4-phenyl-1,2,3,4-tetrahydropyridine-induced Parkinson's disease model by downregulating the activations of nuclear factor-κB, ERK, and JNK. J Neurosci Res (2013) 0.88
Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice. Neurochem Res (2012) 0.88
Temporal and sequential analysis of microglia in the substantia nigra following medial forebrain bundle axotomy in rat. Neuroscience (2003) 0.87
Suppression of neuro inflammation in experimental autoimmune encephalomyelitis by glia maturation factor antibody. Brain Res (2010) 0.85
Edaravone (3-methyl-1-phenyl-2-pyrazolin-5-one), a radical scavenger, prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in the substantia nigra but not the striatum. J Pharmacol Exp Ther (2007) 0.84
1alpha,25-Dihydroxyvitamin D(3) Protects Dopaminergic Neurons in Rodent Models of Parkinson's Disease through Inhibition of Microglial Activation. J Clin Neurol (2006) 0.83
Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol. Neurochem Int (2013) 0.82
Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes. J Mol Neurosci (2014) 0.81
Metalloproteinase-9 contributes to inflammatory glia activation and nigro-striatal pathway degeneration in both mouse and monkey models of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinsonism. Brain Struct Funct (2014) 0.81
CNI-1493 attenuates neuroinflammation and dopaminergic neurodegeneration in the acute MPTP mouse model of Parkinson's disease. Neurodegener Dis (2012) 0.78
Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev (2007) 1.94
Phosphorylation of tau by fyn: implications for Alzheimer's disease. J Neurosci (2004) 1.88
IL-10, an inflammatory/inhibitory cytokine, but not always. Immunol Lett (2003) 1.76
The mast cell in interstitial cystitis: role in pathophysiology and pathogenesis. Urology (2007) 1.67
IL-33 augments substance P-induced VEGF secretion from human mast cells and is increased in psoriatic skin. Proc Natl Acad Sci U S A (2010) 1.56
High levels of intrauterine corticotropin-releasing hormone, urocortin, tryptase, and interleukin-8 in spontaneous abortions. Endocrinology (2003) 1.52
Mast cells as targets of corticotropin-releasing factor and related peptides. Trends Pharmacol Sci (2004) 1.50
Impact of stress and mast cells on brain metastases. J Neuroimmunol (2008) 1.46
Corticotropin-releasing hormone-receptor 2 is required for acute stress-induced bladder vascular permeability and release of vascular endothelial growth factor. BJU Int (2010) 1.46
Acute stress-induced seizures and loss of consciousness in a ten-year-old boy with cutaneous mastocytosis. J Clin Psychopharmacol (2002) 1.45
Chronic fatigue syndrome, mast cells, and tricyclic antidepressants. J Clin Psychopharmacol (2005) 1.44
Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol (2005) 1.31
A novel role of glia maturation factor: induction of granulocyte-macrophage colony-stimulating factor and pro-inflammatory cytokines. J Neurochem (2007) 1.18
IL-1 induces vesicular secretion of IL-6 without degranulation from human mast cells. J Immunol (2003) 1.11
Reduced severity of experimental autoimmune encephalomyelitis in GMF-deficient mice. Neurochem Res (2006) 1.02
Glia maturation factor modulates beta-amyloid-induced glial activation, inflammatory cytokine/chemokine production and neuronal damage. Brain Res (2008) 1.01
Dendritic arbors of developing retinal ganglion cells are stabilized by beta 1-integrins. Mol Cell Neurosci (2006) 0.98
Bile-pancreatic juice exclusion increases p38MAPK activation and TNF-alpha production in ligation-induced acute pancreatitis in rats. Pancreatology (2005) 0.97
The abnormally phosphorylated tau lesion of early Alzheimer's disease. Neurochem Res (2008) 0.96
Autism: an emerging 'neuroimmune disorder' in search of therapy. Expert Opin Pharmacother (2009) 0.95
Mechanism of acute pancreatitis exacerbation by enteral bile-pancreatic juice exclusion. Pancreatology (2004) 0.95
Human mast cells stimulate activated T cells: implications for multiple sclerosis. Ann N Y Acad Sci (2008) 0.92
Skin corticotropin-releasing hormone receptor expression in psoriasis. J Invest Dermatol (2007) 0.92
Glia maturation factor regulation of STAT expression: a novel mechanism in experimental autoimmune encephalomyelitis. Neurochem Res (2007) 0.92
In vitro evidence for role of ERK, p38, and JNK in exocrine pancreatic cytokine production. J Gastrointest Surg (2006) 0.91
Regulation of IL-1-induced selective IL-6 release from human mast cells and inhibition by quercetin. Br J Pharmacol (2006) 0.90
Bile-pancreatic juice exclusion promotes Akt/NF-kappaB activation and chemokine production in ligation-induced acute pancreatitis. J Gastrointest Surg (2006) 0.89
Niacin-induced "flush" involves release of prostaglandin D2 from mast cells and serotonin from platelets: evidence from human cells in vitro and an animal model. J Pharmacol Exp Ther (2008) 0.88
Impaired motor performance and learning in glia maturation factor-knockout mice. Brain Res (2004) 0.88
Enhanced expression of glia maturation factor correlates with glial activation in the brain of triple transgenic Alzheimer's disease mice. Neurochem Res (2012) 0.88
Glia maturation factor induces interleukin-33 release from astrocytes: implications for neurodegenerative diseases. J Neuroimmune Pharmacol (2013) 0.88
IL-32 is increased along with tryptase in lesional psoriatic skin and is up-regulated by substance P in human mast cells. Eur J Dermatol (2010) 0.88
Interleukin-16 network in inflammation and allergy. Allergy Asthma Proc (2002) 0.87
Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content. J Immunol (2009) 0.86
Suppression of neuro inflammation in experimental autoimmune encephalomyelitis by glia maturation factor antibody. Brain Res (2010) 0.85
Urocortin induces interleukin-6 release from rat cardiomyocytes through p38 MAP kinase, ERK and NF-kappaB activation. J Mol Endocrinol (2009) 0.84
Interleukin-17 and the interleukin-17 family member network. Allergy Asthma Proc (2004) 0.83
Systemic inflammation with multiorgan dysfunction is the cause of death in murine ligation-induced acute pancreatitis. J Gastrointest Surg (2011) 0.83
Overexpression of glia maturation factor reinstates susceptibility to myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in glia maturation factor deficient mice. Neurobiol Dis (2010) 0.82
Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists. Int Arch Allergy Immunol (2003) 0.82
Protection of MPTP-induced neuroinflammation and neurodegeneration by Pycnogenol. Neurochem Int (2013) 0.82
Mast cells, T cells, and inhibition by luteolin: implications for the pathogenesis and treatment of multiple sclerosis. Adv Exp Med Biol (2007) 0.82
Interleukin-6 and mast cells. Allergy Asthma Proc (2002) 0.82
Nasal provocation of patients with allergic rhinitis and the hypothalamic-pituitary-adrenal axis. Ann Allergy Asthma Immunol (2007) 0.81
CCK-A receptor induction and P38 and NF-kappaB activation in acute pancreatitis. Pancreatology (2004) 0.81
Glia maturation factor expression in hippocampus of human Alzheimer's disease. Neurochem Res (2013) 0.81
Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes. J Mol Neurosci (2014) 0.81
Interleukin-8 is increased in gingival crevicular fluid from patients with acute pulpitis. J Endod (2008) 0.81
Glia maturation factor expression in entorhinal cortex of Alzheimer's disease brain. Neurochem Res (2013) 0.80
Diminished degradation of myelin basic protein by anti-sulfatide antibody and interferon-gamma in myelin from glia maturation factor-deficient mice. Neurosci Res (2007) 0.80
A novel model of severe gallstone pancreatitis: murine pancreatic duct ligation results in systemic inflammation and substantial mortality. Pancreatology (2010) 0.80
Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells. J Mol Endocrinol (2005) 0.80
Perifollicular and perivascular mouse skin mast cells express corticotropin-releasing hormone receptor. J Invest Dermatol (2006) 0.79
Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli. Int Arch Allergy Immunol (2009) 0.79
Secondary anetoderma associated with mastocytosis. Int Arch Allergy Immunol (2006) 0.78
Amitriptyline and prochlorperazine inhibit proinflammatory mediator release from human mast cells: possible relevance to chronic fatigue syndrome. J Clin Psychopharmacol (2011) 0.78
Inhibitory effect of quercetin on tryptase and MCP-1 chemokine release, and histidine decarboxylase mRNA transcription by human mast cell-1 cell line. Neuroimmunomodulation (2006) 0.78
Bile-pancreatic juice exclusion increases cholinergic M3 and CCK-A receptor expression and interleukin-6 production in ligation-induced acute pancreatitis. Am J Surg (2004) 0.78
Clinical course of myelin oligodendrocyte glycoprotein 35-55 induced experimental autoimmune encephalomyelitis is aggravated by glia maturation factor. Neurochem Int (2011) 0.78
Response of spinal myoclonus to a combination therapy of autogenic training and biofeedback. Biopsychosoc Med (2007) 0.77
Cholinergic receptor induction and JNK activation in acute pancreatitis. Am J Surg (2003) 0.77
Brain metastases of mouse mammary adenocarcinoma is increased by acute stress. Brain Res (2010) 0.77
The isoflavone genistein inhibits proliferation and increases histamine content in human leukemic mast cells. Allergy Asthma Proc (2003) 0.77
Azelastine's inhibition of histamine and tryptase release from human umbilical cord blood-derived cultured mast cells as well as rat skin mast cell-induced vascular permeability: comparison with olopatadine. Allergy Asthma Proc (2002) 0.76
Efficient down-regulation of glia maturation factor expression in mouse brain and spinal cord. Neurochem Res (2012) 0.75
Theophylline as 'add-on' therapy to cetirizine in patients with chronic idiopathic urticaria. A randomized, double-blind, placebo-controlled pilot study. Int Arch Allergy Immunol (2006) 0.75
Topical immunopharmacology of ocular allergies. Curr Opin Allergy Clin Immunol (2002) 0.75